Cargando…

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma

DEAD-box protein 39 (DDX39) has been demonstrated to be a tumorigenic gene in multiple tumor types, but its role in the progression and immune microenvironment of clear cell renal cell cancer (ccRCC) remains unclear. The aim of the present study was to investigate the role of DDX39 in the ccRCC tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Yewei, Jiang, Aimin, Dong, Kai, Gan, Xinxin, Gong, Wenliang, Wu, Zhenjie, Liu, Bing, Bao, Yi, Wang, Jie, Wang, Linhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375229/ https://www.ncbi.nlm.nih.gov/pubmed/34421357 http://dx.doi.org/10.7150/ijbs.62553

Ejemplares similares

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis
por: Jiang, Aimin, et al.
Publicado: (2022)

Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome via Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib Sensitivity
por: Jiang, Aimin, et al.
Publicado: (2022)

Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types
por: Jiang, Aimin, et al.
Publicado: (2022)

Identification and Verification of m(7)G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma
por: Dong, Kai, et al.
Publicado: (2022)

A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma
por: WANG, WEI, et al.
Publicado: (2014)

Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study
por: Wang, Zheng, et al.
Publicado: (2023)

DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1
por: Zhang, Haonan, et al.
Publicado: (2022)

PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
por: Gu, Di, et al.
Publicado: (2022)

High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
por: Wu, Jie, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
por: Tang, Wenbin, et al.
Publicado: (2023)

The DDX39B/FUT3/TGFβR-I axis promotes tumor metastasis and EMT in colorectal cancer
por: He, Chengcheng, et al.
Publicado: (2021)

Pyk2 promotes tumor progression in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2018)

The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate
por: Hirano, Minato, et al.
Publicado: (2023)

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
por: Zhang, Tong, et al.
Publicado: (2018)

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial
por: Park, Jee Soo, et al.
Publicado: (2021)

Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis
por: Wang, Anbang, et al.
Publicado: (2019)

A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategy
por: Jiang, Aimin, et al.
Publicado: (2022)

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
por: Möller, Katharina, et al.
Publicado: (2021)

Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma
por: BAO, WEI, et al.
Publicado: (2023)

Identification of methylation‐driven genes related to prognosis in clear‐cell renal cell carcinoma
por: Wang, Jia, et al.
Publicado: (2019)

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
por: Abdel-Fatah, T M A, et al.
Publicado: (2014)

DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2
por: Zhao, Gang, et al.
Publicado: (2022)

Structural basis for high-order complex of SARNP and DDX39B to facilitate mRNP assembly
por: Xie, Yihu, et al.
Publicado: (2023)

DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2019)

RNF39 mediates K48-linked ubiquitination of DDX3X and inhibits RLR-dependent antiviral immunity
por: Wang, Wenwen, et al.
Publicado: (2021)

Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
por: Wang, Qinchuan, et al.
Publicado: (2019)

DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer
por: Hu, Xinyan, et al.
Publicado: (2022)

Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma
por: Duan, Jiachen, et al.
Publicado: (2022)

SLC39A8/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma
por: Liu, Lilong, et al.
Publicado: (2021)

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer
por: Dai, Ling, et al.
Publicado: (2018)

The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export
por: Saleem, Irfana, et al.
Publicado: (2021)

SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis
por: Wang, Jianfeng, et al.
Publicado: (2021)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8du1bnjugk3pfu4en2nok44enl